Print   



NextGen Group Plc

('NextGen' or 'the Company')

Notice of AGM and Change of Registered Office

The Company gives notice that the Annual General Meeting will be held at the offices of Seymour Pierce Limited at 20 Old Bailey, London EC4M 7EN at 10.00 am on 27 July 2009. The notice convening the Annual General Meeting and Form of Proxy for use at the AGM have been posted to shareholders and are available on the Company's website www.nextgensciences.com.

The Company also wishes to announce that its registered office address has been  to:

8th Floor 

Kildare House 3 Dorset Rise 

London 

EC4Y 8EN.

For further details please contact:

Dr Michael Pisano

CEO, NextGen Group PLC        01480 410 850

Jonathan Wright/Nicola Marrin

Seymour Pierce Limited            020 7107 8000

Notes to Editors:

About NextGen Sciences

NextGen Sciences 

NextGen Sciences (AIM: NGG), the biomarker specialists, provide services to pharmaceutical and biotech companies globally. Using advanced techniques, such as Multiple Reaction Monitoring (MRM) mass spectrometry analysis, the Company is developing a portfolio of robust assays for testing clinical samples for drug safety and efficacy, and the development of personalized treatment for patients. NextGen Sciences' range of services, which include biomarker testing, discovery and assay development, are employed by its customers as a key part of the biomarker-based drug and diagnostic development process. For more information visit www.nextgensciences.com 

NextGen Group PLC floated on the AIM market in London in December 2005 raising £2.4 million in an oversubscribed offering which included strong institutional investor support from Germany as well as in the UK. Further details relating to NextGen Group PLC and its products can be found at www.nextgensciences.com

---

ENDNOAUNRARKRRBRAR